Table 2.
Disability weight (95% UI) | ||
---|---|---|
Infectious disease | ||
1 | Acute episode, mild | 0·027 (0·002-0·113) |
2 | Acute episode, moderate | 0·137 (0·054-0·273) |
3 | Acute episode, severe | 0·152 (0·066-0·288) |
4 | Post-acute consequences (fatigue, emotional lability, and insomnia) | 0·080 (0·020-0·210) |
Diarrhoea | ||
5 | Mild | 0·072 (0·016-0·198) |
6 | Moderate | 0·151 (0·064-0·286) |
7 | Severe | 0·259 (0·170-0·368) |
8 | Epididymo-orchitis | 0·122 (0·044-0·259) |
9 | Herpes zoster | 0·045 (0·006-0·154) |
10 | HIV: symptomatic, pre-AIDS | 0·252 (0·163-0·363) |
11 | HIV/AIDS: receiving antiretroviral (ARV) treatment | 0·074 (0·017-0·201) |
12 | AIDS: not receiving antiretroviral (ARV) treatment | 0·367 (0·309-0·432) |
13 | Intestinal nematode infections: symptomatic | 0·112 (0·037-0·248) |
14 | Lymphatic filariasis: symptomatic | 0·153 (0·067-0·289) |
15 | Ear pain | 0·052 (0·009-0·166) |
Tuberculosis | ||
16 | Not HIV infected | 0·375 (0·319-0·435) |
17 | HIV infected | 0·297 (0·216-0·390) |
Cancer | ||
18 | Diagnosis and primary treatment | 0·264 (0·176-0·371) |
19 | Metastatic | 0·324 (0·251-0·407) |
Terminal phase | ||
20 | With medication (for cancers and end-stage kidney or liver disease) | 0·515 (0·505-0·527) |
21 | Without medication (for cancers and end-stage kidney or liver disease) | 0·411 (0·369-0·454) |
Cardiovascular and circulatory disease | ||
Acute myocardial infarction | ||
22 | Days 1–2 | 0·261 (0·173-0·368) |
23 | Days 3–28 | 0·075 (0·018-0·202) |
Angina pectoris | ||
24 | Mild | 0·037 (0·004-0·135) |
25 | Moderate | 0·055 (0·010-0·173) |
26 | Severe | 0·163 (0·074-0·297) |
27 | Cardiac conduction disorders and cardiac dysrhythmias | 0·256 (0·165-0·364) |
28 | Claudication | 0·021 (0·001-0·095) |
Heart failure | ||
29 | Mild | 0·057 (0·010-0·175) |
30 | Moderate | 0·089 (0·024-0·221) |
31 | Severe | 0·162 (0·073-0·295) |
Stroke | ||
32 | Long-term consequences, mild | 0·053 (0·009-0·169) |
33 | Long-term consequences, moderate | 0·057 (0·010-0·175) |
34 | Long-term consequences, moderate plus cognition problems | 0·111 (0·036-0·247) |
35 | Long-term consequences, severe | 0·355 (0·290-0·423) |
36 | Long-term consequences, severe plus cognition problems | 0·400 (0·353-0·449) |
Diabetes and digestive and genitourinary disease | ||
37 | Diabetic neuropathy | 0·094 (0·027-0·227) |
38 | Chronic kidney disease (stage IV) | 0·080 (0·020-0·210) |
39 | With kidney transplantation | 0·071 (0·016-0·197) |
40 | On dialysis | 0·672 (0·594-0·745) |
41 | Decompensated cirrhosis of the liver | 0·108 (0·035-0·244) |
42 | Gastric bleeding | 0·390 (0·338-0·443) |
43 | Crohn's disease or ulcerative colitis | 0·135 (0·053-0·271) |
44 | Benign prostatic hypertrophy: symptomatic | 0·088 (0·023-0·221) |
45 | Urinary incontinence | 0·234 (0·143-0·351) |
46 | Stress incontinence | 0·044 (0·006-0·151) |
47 | Impotence | 0·058 (0·011-0·177) |
Infertility | ||
48 | Primary | 0·026 (0·002-0·111) |
49 | Secondary | 0·018 (0·001-0·088) |
50 | Often has a burning sensation in the back of the chest after eating | 0·088 (0·024-0·219) |
Chronic respiratory disease | ||
Asthma | ||
51 | Controlled | 0·032 (0·003-0·126) |
52 | Partially controlled | 0·081 (0·020-0·211) |
53 | Uncontrolled | 0·227 (0·136-0·346) |
Chronic obstructive pulmonary disease (COPD) and other chronic respiratory diseases | ||
54 | Mild | 0·022 (0·002-0·101) |
55 | Moderate | 0·176 (0·086-0·308) |
56 | Severe | 0·284 (0·200-0·383) |
Neurological disorders | ||
Dementia | ||
57 | Mild | 0·047 (0·007-0·157) |
58 | Moderate | 0·167 (0·077-0·300) |
59 | Severe | 0·276 (0·191-0·378) |
Headache | ||
60 | Migraine | 0·416 (0·375-0·457) |
61 | Tension-type | 0·153 (0·065-0·288) |
62 | Medication overuse | 0·184 (0·093-0·314) |
Multiple sclerosis | ||
63 | Mild | 0·129 (0·048-0·266) |
64 | Moderate | 0·389 (0·340-0·442) |
65 | Severe | 0·661 (0·586-0·731) |
Epilepsy | ||
66 | Severe (seizures >= once a month) | 0·462 (0·441-0·481) |
67 | Less severe (seizures 1-11 per year) | 0·415 (0·376-0·457) |
Parkinson's disease | ||
68 | Mild | 0·033 (0·003-0·129) |
69 | Moderate | 0·318 (0·241-0·403) |
70 | Severe | 0·475 (0·458-0·488) |
Mental, behavioural, and substance use disorders | ||
Alcohol use disorder | ||
71 | Very mild | 0·060 (0·011-0·180) |
72 | Mild | 0·144 (0·058-0·280) |
73 | Moderate | 0·225 (0·133-0·344) |
74 | Severe | 0·289 (0·202-0·386) |
Fetal alcohol syndrome | ||
75 | Mild | 0·028 (0·003-0·115) |
76 | Moderate | 0·109 (0·036-0·245) |
77 | Severe | 0·201 (0·109-0·326) |
Cannabis dependence | ||
78 | Mild | 0·38 (0·327-0·438) |
79 | Severe | 0·597 (0·55-0·645) |
Amphetamine dependence | ||
80 | Mild | 0·318 (0·241-0·404) |
81 | Severe | 0·622 (0·565-0·679) |
Cocaine dependence | ||
82 | Mild | 0·287 (0·205-0·385) |
83 | Severe | 0·497 (0·486-0·506) |
Heroin and other opioid dependence | ||
84 | Mild | 0·494 (0·483-0·502) |
85 | Severe | 0·752 (0·640-0·841) |
Anxiety disorders | ||
86 | Mild | 0·029 (0·003-0·118) |
87 | Moderate | 0·115 (0·040-0·253) |
88 | Severe | 0·556 (0·528-0·588) |
Major depressive disorder | ||
89 | Mild episode | 0·053 (0·009-0·168) |
90 | Moderate episode | 0·509 (0·500-0·520) |
91 | Severe episode | 0·699 (0·608-0·777) |
Bipolar disorder | ||
92 | Manic episode | 0·501 (0·492-0·510) |
93 | Residual state | 0·060 (0·012-0·181) |
Schizophrenia | ||
94 | Acute state | 0·711 (0·616-0·797) |
95 | Residual state | 0·590 (0·548-0·633) |
96 | Anorexia nervosa | 0·093 (0·026-0·226) |
97 | Bulimia nervosa | 0·070 (0·015-0·195) |
98 | Attention deficit hyperactivity disorder | 0·028 (0·002-0·116) |
99 | Conduct disorder | 0·241 (0·149-0·354) |
100 | Borderline intellectual functioning | 0·015 (0·001-0·078) |
Intellectual disability/mental retardation | ||
101 | Mild | 0·075 (0·018-0·202) |
102 | Moderate | 0·096 (0·028-0·229) |
103 | Severe | 0·115 (0·039-0·252) |
104 | Profound | 0·228 (0·136-0·348) |
Hearing and vision loss | ||
Hearing loss | ||
105 | Mild | 0·031 (0·003-0·122) |
106 | Moderate | 0·068 (0·014-0·192) |
107 | Severe | 0·246 (0·156-0·358) |
108 | Profound | 0·200 (0·109-0·327) |
109 | Complete | 0·151 (0·065-0·287) |
110 | Mild, with ringing | 0·042 (0·006-0·146) |
111 | Moderate, with ringing | 0·076 (0·017-0·204) |
112 | Severe, with ringing | 0·233 (0·140-0·351) |
113 | Profound, with ringing | 0·183 (0·093-0·313) |
114 | Complete, with ringing | 0·236 (0·145-0·353) |
Distance vision | ||
115 | Mild impairment | 0·009 (0·0003-0·057) |
116 | Moderate impairment | 0·040 (0·005-0·144) |
117 | Severe impairment | 0·219 (0·127-0·340) |
118 | Blindness | 0·221 (0·129-0·341) |
119 | Monocular | 0·052 (0·008-0·165) |
120 | Presbyopia | 0·016 (0·001-0·081) |
Musculoskeletal disorders | ||
Low back pain | ||
121 | Mild | 0·046 (0·007-0·156) |
122 | Moderate | 0·115 (0·039-0·250) |
123 | Severe, without leg pain | 0·164 (0·076-0·298) |
124 | Severe, with leg pain | 0·180 (0·089-0·311) |
125 | Most severe, without leg pain | 0·180 (0·090-0·312) |
126 | Most severe, with leg pain | 0·188 (0·095-0·317) |
Neck pain | ||
127 | Mild | 0·047 (0·007-0·159) |
128 | Moderate | 0·070 (0·015-0·196) |
129 | Severe | 0·126 (0·045-0·263) |
130 | Most severe | 0·106 (0·033-0·242) |
Musculoskeletal problems | ||
131 | Legs, mild | 0·043 (0·006-0·149) |
132 | Legs, moderate | 0·122 (0·043-0·259) |
133 | Legs, severe | 0·162 (0·073-0·294) |
134 | Arms, mild | 0·047 (0·007-0·157) |
135 | Arms, moderate | 0·123 (0·044-0·260) |
136 | Generalized, moderate | 0·138 (0·055-0·275) |
137 | Generalized, severe | 0·306 (0·228-0·396) |
138 | Gout, acute | 0·212 (0·119-0·335) |
Injury | ||
139 | Amputation of one upper limb (long term, without treatment) | 0·117 (0·040-0·253) |
140 | Concussion (short term) | 0·083 (0·021-0·213) |
141 | Spinal cord lesion, below neck level (treated) | 0·359 (0·297-0·425) |
Other | ||
Abdominopelvic problem | ||
142 | Mild | 0·039 (0·005-0·143) |
143 | Moderate | 0·175 (0·084-0·307) |
144 | Severe | 0·420 (0·382-0·459) |
Anaemia | ||
145 | Mild | 0·009 (0·0003-0·057) |
146 | Moderate | 0·094 (0·026-0·226) |
147 | Severe | 0·179 (0·088-0·310) |
148 | Periodontitis | 0·019 (0·001-0·091) |
149 | Dental caries: symptomatic | 0·018 (0·001-0·087) |
150 | Severe tooth loss | 0·046 (0·007-0·156) |
Disfigurement | ||
151 | Level 1 | 0·048 (0·007-0·159) |
152 | Level 2 | 0·154 (0·067-0·289) |
153 | Level 3 | 0·572 (0·537-0·608) |
154 | Level 1, with itch or pain | 0·063 (0·013-0·186) |
155 | Level 2, with itch or pain | 0·192 (0·100-0·321) |
156 | Level 3, with itch or pain | 0·625 (0·567-0·683) |
Generic uncomplicated disease | ||
157 | Worry and daily medication | 0·045 (0·006-0·153) |
158 | Anxiety about diagnosis | 0·018 (0·001-0·087) |
159 | Kwashiorkor | 0·079 (0·019-0·207) |
160 | Severe wasting | 0·154 (0·067-0·287) |
161 | Speech problems | 0·041 (0·005-0·146) |
Motor impairment | ||
162 | Mild | 0·029 (0·003-0·119) |
163 | Moderate | 0·044 (0·006-0·151) |
164 | Severe | 0·262 (0·174-0·370) |
Motor plus cognitive impairments | ||
165 | Mild | 0·036 (0·004-0·135) |
166 | Moderate | 0·075 (0·017-0·202) |
167 | Severe | 0·271 (0·184-0·373) |
168 | Rectovaginal fistula | 0·340 (0·271-0·416) |
169 | Vesicovaginal fistula | 0·229 (0·136-0·347) |
170 | Thrombocytopenic purpura | 0·131 (0·05-0·268) |
171 | Hypothyroidism | 0·030 (0·003-0·120) |
172 | Hyperthyroidism | 0·117 (0·040-0·253) |
173 | Neck pain, moderate | 0·103 (0·032-0·240) |
174 | Osteomyelitis | 0·107 (0·034-0·242) |
175 | Shoulder lesions | 0·031 (0·003-0·123) |
176 | Heart burn & reflux “GERD” | 0·092 (0·025-0·225) |
177 | Constipation | 0·061 (0·012-0·181) |
178 | Vaginal discharge | 0·028 (0·002-0·115) |
179 | Dyspareunia | 0·044 (0·006-0·151) |
180 | Stress incontinence | 0·046 (0·006-0·155) |
181 | Irritable bowel syndrome | 0·045 (0·006-0·151) |
182 | Somatoform disorder | 0·097 (0·028-0·231) |
183 | Borderline personality disorder | 0·196 (0·103-0·322) |
184 | Harmful alcohol use | 0·098 (0·029-0·233) |
185 | Vertigo and balance disorder (Menière, labyrinthitis) | 0·065 (0·013-0·186) |
186 | Trigeminal neuralgia | 0·088 (0·024-0·22) |
187 | Encephalopathy - moderate | 0·175 (0·085-0·306) |
188 | Encephalopathy - severe | 0·285 (0·200-0·383) |
189 | Thrombocytopenic purpura | 0·141 (0·056-0·277) |
190 | Lymphogranuloma Venereum - local infection | 0·104 (0·032-0·238) |
191 | Subacute sclerosing panencephalitis - phase 1 | 0·056 (0·010-0·173) |
192 | Subacute sclerosing panencephalitis - phase 2 | 0·151 (0·065-0·286) |
194 | Haemorrhoids | 0·091 (0·025-0·224) |
195 | Anal fissure/abcess/fistula | 0·069 (0·015-0·194) |
196 | Hyperthyroidism | 0·073 (0·016-0·198) |
197 | Allergic rhinitis (hay fever) | 0·015 (0·001-0·076) |
198 | Varicose veins | 0·039 (0·005-0·141) |
199 | Carpal tunnel syndrome | 0·028 (0·003-0·117) |
200 | Intensive care unit admission | 0·669 (0·589-0·741) |
201 | Invasive device/drain | 0·175 (0·084-0·307) |
202 | Insomnia | 0·040 (0·005-0·144) |
203 | Sleep apnoea | 0·080 (0·020-0·209) |
204 | Hypothyroidism | 0·042 (0·006-0·146) |
205 | Hearing loss, moderate (Modified)* | 0·068 (0·014-0·193) |
206 | Hearing loss, severe (Modified)* | 0·222 (0·131-0·342) |
Health state ‘Subacute sclerosing panencephalitis - phase 2’ numbered 193 was omitted in probit analysis due to its collinearity. Thus, we didn't report DW value of this health state finally. * We modified the two lay descriptions of moderate and severe hearing loss health states in our study.